Latest Breast cancer treatment Stories
AUSTIN, Texas, April 26, 2012 /PRNewswire/ -- A clinical trial has demonstrated that Oncoprex® (TUSC2 nanoparticles) can be safely administered in advanced lung cancer patients to halt cancer or shrink primary and metastatic tumors in some patients. The clinical trial results were published April 26, 2012 in a paper entitled, "Phase I Clinical Trial of Systemically Administered TUSC2 (FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans" in the journal PLoS One, an...
Researchers say drug based on their discovery might target several tumor types A single gene that promotes initial development of the most common form of lung cancer and its lethal metastases has been identified by researchers at Mayo Clinic in Florida. Their study suggests other forms of cancer may also be driven by this gene, matrix metalloproteinase-10 (MMP-10). The study, published in the journal PLoS ONE on April 24, shows that MMP-10 is a growth factor secreted and then used by...
MADISON, Wis., April 24, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has successfully completed the first cohort in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404 (LIGHT), a cancer-targeted PET imaging agent, in patients with advanced...
SAN DIEGO, April 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe. The study demonstrated the therapy's ability to provide local tumor...
Connie K. Ho for RedOrbit.com Breast cancer is a global epidemic with 1.4 million women suffering from it each year. However, progress has been made as researchers in Canada and the U.K. have found that breast cancer is not one disease but 10. The new categories could improve treatment for patients, tailoring drugs for personalized treatment and helping predict more accurate survival rates. The study, released in the journal Nature, looked at breast cancer samples from 2,000 women....
(Ivanhoe Newswire) -- Now women suffering from breast cancer have a way to improve their overall quality of life. Researchers show that exercise during cancer treatment helps reduce depression and severe fatigue in women. "Women who are physically active may also have more confidence in their own ability to continue with family-related, household, work-related, or social activities, which bring meaning and satisfaction to their lives," Jamie M. Stagl, M.S., doctoral student in Clinical...
In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases "en masse", enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies. Kinases are proteins expressed in human tissues that play a key role in cell growth, particularly in cancer. Of the 518 known human kinases, about 400 are expressed in cancers,...
Biomarkers which could help to predict resistance to chemotherapy in breast cancer patients have been identified by researchers from the University of Hull, UK. The researchers found a family of proteins to be twice as prevalent in clinical samples obtained from breast cancer patients who were resistant to chemotherapy than those who were successfully treated. Chemotherapy resistance is a major problem for some types of breast cancer and many patients undergo treatment that does not...
Peroxiredoxin 2 protects tumor cells from oxidative stress and promotes their growth and proliferation in the lung Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases. The study results have been advanced in the...
Combining two strategies designed to improve the results of cancer treatment – antiangiogenesis drugs and nanomedicines – may only be successful if the smallest nanomedicines are used. A new study from Massachusetts General Hospital (MGH) researchers, appearing in Nature Nanotechnology, finds that normalizing blood vessels within tumors, which improves the delivery of standard chemotherapy drugs, can block the delivery of larger nanotherapy molecules. "We found that vascular...
